Get the Stockscreener App
1.08
2.06%
0.0218
Anebulo Pharmaceuticals Inc Stock (ANEB) Forecast
The Anebulo Pharmaceuticals Inc (ANEB) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $1.029, representing a -4.73% decrease from the current price of $1.08. The highest analyst price target is $2.0382, and the lowest is $0.0197.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ANEB Price Target
Average 1.0249
(-5.10% Downside)
Is Anebulo Pharmaceuticals Inc (ANEB) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.83 | Neutral |
| STOCH(9,6) | 46.04 | Neutral |
| STOCHRSI(14) | 72.57 | Neutral |
| MACD(12,26) | -0.01 | Buy |
| ADX(14) | 23.73 | Neutral |
| William %R | -44.27 | Neutral |
| CCI(14) | 20.39 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.0803
Sell
|
1.07
Buy
|
| MA20 |
1.0559
Buy
|
1.0726
Buy
|
| MA50 |
1.1046
Sell
|
1.1319
Sell
|
| MA100 |
1.2824
Sell
|
1.2632
Sell
|
| MA200 |
1.5222
Sell
|
1.5429
Sell
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, ANEB could be considered a Moderate Sell, with 17 technical analysis indicators signaling 4 Buy signals, 7 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ANEB, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 49.83 indicates that ANEB is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 46.04 indicates that ANEB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 72.57 indicates that ANEB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.73 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 20.39 indicates that ANEB is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ANEB price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Anebulo Pharmaceuticals Inc financial reports and earnings history, Anebulo Pharmaceuticals Inc (ANEB) stock could reach $1.9418 by 2030, $16.92 by 2040 and $25.98 by 2050. See the projected annual prices until 2050 of the Anebulo Pharmaceuticals Inc stock below:
- Anebulo Pharmaceuticals Inc (ANEB) is expected to reach an average price of $9.4353 in 2035, with a high prediction of $9.0871 and a low estimate of $8.8882. This indicates an $773.64% rise from the last recorded price of $1.08.
- Anebulo Pharmaceuticals Inc (ANEB) stock is projected to chart a bullish course in 2040, with an average price target of $17.13, representing an $1,486% surge from its current level. The forecast ranges from a conservative $5.6577 to a sky-high $16.92.
- Our analysts predict Anebulo Pharmaceuticals Inc (ANEB) to jump 1,365% by 2045, soaring from $15.91 to an average price of $15.82, potentially reaching $15.76. While $15.91 is the low estimate, the potential upside is significant.
- Anebulo Pharmaceuticals Inc (ANEB) stock is expected to climb by 2050, reaching an average of $25.66, a $2,276% jump from its current level. However, a wide range of estimates exists, with high and low targets of $25.98 and $25.66, respectively, highlighting the market's uncertainty.
Anebulo Pharmaceuticals Inc Stock (ANEB) Year by Year Forecast
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2025
Anebulo Pharmaceuticals Inc Stock (ANEB) is expected to reach an average price of $2.1947 in 2025, with a high prediction of $4.3697 and a low estimate of $0.0197. This indicates an +103.21% rise from the last recorded price of $1.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2025 | $0.0647 | $0.0197 | $2.0382 | -94.01% |
| August, 2025 | $0.2588 | $0.1088 | $0.8988 | -76.03% |
| September, 2025 | $0.5024 | $0.0947 | $0.5847 | -53.48% |
| October, 2025 | $0.4619 | $0.3642 | $0.4213 | -57.24% |
| November, 2025 | $0.5154 | $0.2895 | $0.6046 | -52.28% |
| December, 2025 | $0.1951 | $0.2049 | $0.6109 | -81.93% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2026
The predicted value for Anebulo Pharmaceuticals Inc (ANEB) in 2026 is set at an average of $0.9035. Estimates vary from a peak of $1.7953 to a trough of $0.0117, indicating an -16.34% surge from the present price of $1.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.3129 | $0.0316 | $0.6092 | -71.03% |
| February, 2026 | $0.028 | $0.028 | $0.3939 | -97.41% |
| March, 2026 | $0.2644 | $0.0117 | $0.6721 | -75.52% |
| April, 2026 | $0.1349 | $0.0126 | $0.5685 | -87.51% |
| May, 2026 | $0.2486 | $0.2486 | $0.2678 | -76.98% |
| June, 2026 | $0.2719 | $0.1903 | $0.3196 | -74.83% |
| July, 2026 | $0.1872 | $0.1057 | $0.1492 | -82.66% |
| August, 2026 | $0.4748 | $0.1434 | $1.0347 | -56.04% |
| September, 2026 | $0.9453 | $0.213 | $1.7953 | -12.47% |
| October, 2026 | $0.2619 | $0.0482 | $1.4695 | -75.75% |
| November, 2026 | $0.1018 | $0.0401 | $0.7859 | -90.57% |
| December, 2026 | $0.2988 | $0.0454 | $0.4764 | -72.34% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Anebulo Pharmaceuticals Inc (ANEB) is $0.796, with a high forecast of $1.5391 and a low forecast of $0.0529. This indicates an -26.30% decrease from the last price of $1.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.4052 | $0.0529 | $0.816 | -62.48% |
| February, 2027 | $0.4666 | $0.2993 | $0.5865 | -56.79% |
| March, 2027 | $0.9622 | $0.5057 | $1.3981 | -10.91% |
| April, 2027 | $0.7086 | $0.5886 | $1.4045 | -34.39% |
| May, 2027 | $1.13 | $0.5827 | $1.3509 | +4.63% |
| June, 2027 | $1.0582 | $0.8632 | $1.5391 | -2.02% |
| July, 2027 | $1.1735 | $1.0017 | $1.0235 | +8.66% |
| August, 2027 | $1.2607 | $1.1089 | $0.7671 | +16.73% |
| September, 2027 | $0.9796 | $0.8778 | $0.9958 | -9.30% |
| October, 2027 | $1.2866 | $1.0021 | $0.8967 | +19.13% |
| November, 2027 | $0.8438 | $1.2621 | $0.8685 | -21.87% |
| December, 2027 | $0.3028 | $0.5558 | $0.7156 | -71.97% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2028
In 2028, Anebulo Pharmaceuticals Inc (ANEB) is projected to reach an average price of $1.9226, with a high projection of $3.662 and a low estimate of $0.1832. This indicates an +78.02% rise from the last price of $1.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.4999 | $0.3981 | $0.6669 | -53.71% |
| February, 2028 | $0.357 | $0.427 | $0.673 | -66.94% |
| March, 2028 | $0.2041 | $0.1832 | $0.8594 | -81.11% |
| April, 2028 | $3.1131 | $0.5977 | $2.3231 | +188.25% |
| May, 2028 | $3.982 | $3.0101 | $3.662 | +268.70% |
| June, 2028 | $1.5791 | $3.7991 | $3.3838 | +46.22% |
| July, 2028 | $3.3563 | $1.5994 | $1.8462 | +210.77% |
| August, 2028 | $2.8152 | $2.5934 | $3.2098 | +160.67% |
| September, 2028 | $2.3523 | $2.9923 | $2.8565 | +117.81% |
| October, 2028 | $3.0694 | $2.7141 | $2.9076 | +184.21% |
| November, 2028 | $3.1984 | $3.3384 | $3.4748 | +196.15% |
| December, 2028 | $3.6355 | $3.4683 | $3.4055 | +236.62% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2029
The 2029 price forecast for Anebulo Pharmaceuticals Inc Stock (ANEB) is $2.1936 on average, with a high prediction of $3.1562 and a low estimate of $1.2311. This represents an +103.12% increase from the previous price of $1.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.2707 | $3.1791 | $2.8973 | +202.84% |
| February, 2029 | $2.9214 | $3.0098 | $3.1562 | +170.50% |
| March, 2029 | $2.5537 | $2.6787 | $2.8333 | +136.45% |
| April, 2029 | $2.5559 | $2.5401 | $2.3905 | +136.66% |
| May, 2029 | $2.4246 | $2.5628 | $2.4794 | +124.50% |
| June, 2029 | $2.7769 | $2.4065 | $2.7769 | +157.12% |
| July, 2029 | $2.479 | $2.699 | $2.7037 | +129.54% |
| August, 2029 | $2.4568 | $2.5639 | $2.5543 | +127.48% |
| September, 2029 | $2.575 | $2.5015 | $2.575 | +138.43% |
| October, 2029 | $1.804 | $1.8522 | $1.654 | +67.03% |
| November, 2029 | $1.2011 | $1.2311 | $1.9057 | +11.21% |
| December, 2029 | $1.6882 | $1.4529 | $1.3982 | +56.32% |
Anebulo Pharmaceuticals Inc Stock (ANEB) Price Forecast for 2030
Anebulo Pharmaceuticals Inc Stock (ANEB) is expected to reach an average price of $2.7437 in 2030, with a high forecast of $4.9853 and a low forecast of $0.5021. This signifies an +154.05% surge from the last price of $1.08.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $2.0671 | $2.1299 | $1.9418 | +91.40% |
| February, 2030 | $1.7843 | $1.9575 | $1.859 | +65.21% |
| March, 2030 | $1.6014 | $1.6296 | $1.7561 | +48.28% |
| April, 2030 | $1.3135 | $1.4385 | $1.4668 | +21.62% |
| May, 2030 | $1.0275 | $0.9257 | $1.1603 | -4.86% |
| June, 2030 | $1.1346 | $0.9692 | $1.1146 | +5.06% |
| July, 2030 | $0.7899 | $0.7717 | $0.6991 | -26.86% |
| August, 2030 | $4.9443 | $0.5021 | $4.9443 | +357.80% |
| September, 2030 | $4.9457 | $4.9776 | $4.9853 | +357.93% |
| October, 2030 | $5.0513 | $4.8871 | $4.8871 | +367.72% |
| November, 2030 | $4.482 | $4.7267 | $4.362 | +315.00% |
| December, 2030 | $5.2927 | $4.9774 | $4.6751 | +390.07% |
0.87%
0.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):